Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Lodi

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
The Lancet. HIV|October 2, 2015
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort studySara Lodi, Andrew Phillips, Roger Logan, et al.
AIDS (London, England)|February 19, 2025
Time to direct-acting antiviral initiation and liver-related events in people with HIV and hepatitis C virusMathieu Chalouni, Daniela K Van Santen, Juan Berenguer, et al.
AIDS (London, England)|May 2, 2012
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational studyLauren E Cain, Andrew Phillips, Sara Lodi, et al.
AIDS (London, England)|March 25, 2026
Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for Hepatitis C virus in people with HIVMathieu Chalouni, Jessie Torgersen, Christopher T Rentsch, et al.
American Journal of Epidemiology|May 8, 2019
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With ApplesSara Lodi, Andrew Phillips, Jens Lundgren, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2025
Risk of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C virus infection in people with HIVDaniela K van Santen, Mathieu Chalouni, Juan Berenguer, et al.
JAMA Network Open|September 27, 2023
Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials: A Systematic ReviewHarrison J Hansford, Aidan G Cashin, Matthew D Jones, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological ConditionsEllen C Caniglia, Andrew Phillips, Kholoud Porter, et al.
PLOS Global Public Health|April 28, 2023
Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effectiveCarly A Rodriguez, Sara Lodi, C Robert Horsburgh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2017
Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or OlderSara Lodi, Dominique Costagliola, Caroline Sabin, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
The Lancet. HIV|October 2, 2015
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort studySara Lodi, Andrew Phillips, Roger Logan, et al.
AIDS (London, England)|February 19, 2025
Time to direct-acting antiviral initiation and liver-related events in people with HIV and hepatitis C virusMathieu Chalouni, Daniela K Van Santen, Juan Berenguer, et al.
AIDS (London, England)|May 2, 2012
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational studyLauren E Cain, Andrew Phillips, Sara Lodi, et al.
AIDS (London, England)|March 25, 2026
Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for Hepatitis C virus in people with HIVMathieu Chalouni, Jessie Torgersen, Christopher T Rentsch, et al.
American Journal of Epidemiology|May 8, 2019
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With ApplesSara Lodi, Andrew Phillips, Jens Lundgren, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2025
Risk of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C virus infection in people with HIVDaniela K van Santen, Mathieu Chalouni, Juan Berenguer, et al.
JAMA Network Open|September 27, 2023
Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials: A Systematic ReviewHarrison J Hansford, Aidan G Cashin, Matthew D Jones, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological ConditionsEllen C Caniglia, Andrew Phillips, Kholoud Porter, et al.
PLOS Global Public Health|April 28, 2023
Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effectiveCarly A Rodriguez, Sara Lodi, C Robert Horsburgh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2017
Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or OlderSara Lodi, Dominique Costagliola, Caroline Sabin, et al.
Pageof 11